AGIO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Agios Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 27.21 USD 0.85%

Market Cap: $1.6B

	Agios Pharmaceuticals Inc NASDAQ:AGIO	US
	Clarke Inc TSX:CKI	CA

Profitability Summary

Agios Pharmaceuticals Inc's profitability score is 23/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

90% > 88%

Negative Operating Margin

-874%

Negative 3Y Average Operating Margin

-883%

Operating Margin is Increasing

-1 990% > -874%

Negative Net Margin

-764%

Negative 3Y Average Net Margin

-96%

Net Margin is Increasing

-1 146% > -764%

Negative Free Cash Flow Margin

-698%

Negative 3Y Average Free Cash Flow Margin

-1 103%

Free Cash Flow Margin is Increasing

-1 627% > -698%

Negative ROE

-30%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-56%

ROIC is Increasing

-94% > -80%

View All

Hide

Collapse

23 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.